Type 2 DiabetesInfo Center
Popular Diabetes Rx May Not Cut Bladder Cancer Risk
Widely given to patients with type 2 diabetes, metformin has been linked to reducing the risk for many types of cancers. The medication, however, may not be effective against one certain cancer.
Diabetes Medications May Impact Cancer Risks
People with type 2 diabetes have higher cancer risks than the general population. The link may have to do with how diabetes affects the metabolism. Diabetes medications may also figure into the equation.
Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
New Diabetes Rx Delivers Results
While several medications are already on the market to treat diabetes, not all patients have the desired control over their blood sugar levels. Alogliptin may offer a fresh option.
New Guidance on Actos or Takeda
If you've been taking Actos or Takeda for more than a year to control your type 2 diabetes, you will want to be in touch with your family physician or endocrinologist. A link with bladder cancer has been discovered.
Sales of Diabetes Drugs Stopped Due to Bladder Cancer Risks
Actos and Competact, two top-selling type 2 diabetes drugs, have been pulled off the markets in France and Germany following studies linking the medications to bladder cancer.
A new study suggests that lower potassium levels in the blood of African-Americans may help explain why they are more likely than whites to develop type 2 diabetes.
The Key is in the Pee
Scientists have developed a simple home urine test that can determine if patients with type 1 and type 2 diabetes are producing their own insulin.
Not Yet Suitable for Children
A simple blood glucose test commonly used to diagnose diabetes and pre-diabetes may not be the best method for diagnosing diabetes in children, according to a new study from the University of Michigan.
Pass the Salt!
Current guidelines tell diabetes patients to reduce the amount of salt in their diets. However, a new study by Australian researchers challenges this advice.